R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, announces that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice (“CD&R”), in an all-cash transaction with an enterprise value of approximately $8.9 billion. “R1 is a trusted partner in healthcare technology and automation,” said Ravi Sachdev, Partner at CD&R. “We see tremendous opportunity to build on R1’s differentiated platform to continue delivering solutions to help healthcare providers operate more efficiently and reduce costs in the system.”
Read the full article: R1 RCM to Be Acquired by TowerBrook and CD&R for $8.9B //
Source: https://www.globenewswire.com/news-release/2024/08/01/2922679/0/en/R1-RCM-to-be-Acquired-by-TowerBrook-and-CD-R-for-8-9-Billion.html